Skip to main content
. Author manuscript; available in PMC: 2009 Apr 21.
Published in final edited form as: Neurology. 2008 Apr 9;70(19):1664–1671. doi: 10.1212/01.wnl.0000306696.82017.66

Table 3.

Relationship between Aβ levels in 1998–1999 and incident mild cognitive impairment in 2002–2003 in normal subjects (all subjects)

Model 1
Model 2
Model 3
Model 4
OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
Aβ-40 1.39 (0.99–1.96) 0.05 1.34 (0.95–1.89) 0.09 1.47 (1.00–2.16) 0.05 1.61 (1.03–2.53) 0.03
Aβ-42 1.30 (0.93–1.83) 0.13 1.27 (0.90–1.79) 0.17 1.28 (0.90–1.83) 0.17 1.34 (0.90–1.99) 0.14
Aβ-42/Aβ-40 1.07 (0.78–1.49) 0.66 1.07 (0.77–1.49) 0.66 1.04 (0.75–1.45) 0.80 1.06 (0.74–1.54) 0.74

Model 1: unadjusted; Model 2: adjusted for age; Model 3: adjusted for age and cystatin C level; Model 4: adjusted for age, Modified Mini-Mental State Examination scores, cystatin C, APOE-4, and MRI identified infarcts. The odds ratios (ORs) were estimated with increments of 1 SD of plasma Aβ1-40 and Aβ1-42.